Sangamo Therapeutics
SGMO
#10549
Rank
โ‚ฌ27.94 M
Marketcap
0,06746ย โ‚ฌ
Share price
0.00%
Change (1 day)
-80.05%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2026 (TTM): -0,32ย โ‚ฌ

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,35ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,40ย โ‚ฌ an increase over its 2024 EPS that were of -0,46ย โ‚ฌ.

EPS history for Sangamo Therapeutics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,32ย โ‚ฌ-19.13%
2025-0,40ย โ‚ฌ-13.73%
2024-0,46ย โ‚ฌ
2022-1,14ย โ‚ฌ0.81%
2021-1,13ย โ‚ฌ33.33%
2020-0,85ย โ‚ฌ6.9%
2019-0,79ย โ‚ฌ22.54%
2018-0,65ย โ‚ฌ1.43%
2017-0,64ย โ‚ฌ-31.37%
2016-0,93ย โ‚ฌ75.86%
2015-0,53ย โ‚ฌ48.72%
2014-0,36ย โ‚ฌ-17.02%
2013-0,43ย โ‚ฌ9.3%
2012-0,39ย โ‚ฌ-39.44%
2011-0,65ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
6,09ย โ‚ฌ-1,857.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
15,84ย โ‚ฌ-4,673.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
2,15ย โ‚ฌ-721.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-1,16ย โ‚ฌ 234.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-2,83ย โ‚ฌ 715.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
0,91ย โ‚ฌ-361.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
18,06ย โ‚ฌ-5,313.16%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-0,08204ย โ‚ฌ-76.32%๐Ÿ‡บ๐Ÿ‡ธ USA